A Study of Tagmokitug in Combination With Other Treatments in Participants With Advanced or Metastatic Solid Tumors
Trial details
- Registry ID
- NCT07945821
- Phase
- Phase 1, Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of Tagmokitug in Combination With Other Treatments in Participants With Advanced or Metastatic Solid TumorsNCT07945821 | CHRS | Phase 1, Phase 2 | Recruiting | 2028-08Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |